EOC Pharma Group Partners with China National Accord Medicines for Distribution Rights
China-based EOC Pharma Group has announced a strategic partnership with compatriot firm China National Accord...
Company
Ubrigene Secures RMB 150 Million in Series C+ Financing to Expand Global CGT CDMO Platform
Yiming Cell Biotechnology Co., Ltd, known as Ubrigene Biosciences Inc., a leading gene and cell...
Shanghai Huikai Medical Technology Secures Series A+ Funding for Prostate Stent System
Shanghai Huikai Medical Technology Co., Ltd, a China-based urology device manufacturer, has reportedly raised tens...
Shandong Jincheng Pharmaceutical Initiates Phase II Study for LT-01 Antibacterial Drug
Shandong Jincheng Pharmaceutical Group Co., Ltd. (SHE: 300233), China’s largest cephalosporin manufacturer, has announced receiving...
RemeGen Ltd Partners with Shandong Cancer Hospital for ADC Development and Integrated System
RemeGen Ltd (HKG: 9995) has announced a strategic partnership with Shandong Cancer Hospital to establish...
Nona Biosciences Partners with Dr. Michael S. Diamond for Viral Disease Monoclonal Antibody Research
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), which operates in the...
Everest Medicines and SPH Keyuan Ink MoU to Expand Xerava Distribution in China
China-based Everest Medicines (HKG: 1952) has announced a Memorandum of Understanding (MoU) with a subsidiary...
Innovent Biologics Presents IBI351 Phase I Results at AACR Annual Meeting
China-based Innovent Biologics (HKG: 1801) has published the results of a Phase I clinical study...
China Resources Biopharmaceutical Partners with Hefei Institute and Afana Bio for Joint Lab
China Resources Biopharmaceutical Co., Ltd has announced a strategic partnership with the Hefei Comprehensive National...
XZenith Biopharm Completes Enrollment in Phase II Study for Proton Pump Inhibitor
XZenith Biopharm, a Chinese company with minority ownership by Sihuan Pharma, has completed patient enrollment...
Adagene Inc. Presents Positive Interim Results for ADG126 at AACR Annual Meeting
China-based Adagene Inc. (NASDAQ: ADAG) has announced interim results from its combination dose escalation studies...
BeiGene and SpringWorks Therapeutics Report Positive Phase Ib Results for Lifirafenib and Mirdametinib Combination
China-based BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) and SpringWorks Therapeutics Inc., (NASDAQ: SWTX) have...
HanchorBio Receives FDA Approval for Multi-Region Clinical Study of HCB101 Fusion Protein
Taiwan-based HanchorBio has announced receiving the green light from the US FDA to conduct a...
Hainan’s Boao Lecheng Partners with Sonova to Advance Hearing Health Solutions in China
The Boao Lecheng Medical Tourism Pilot Zone of Hainan Province has struck a strategic partnership...
Nanjing Chamlion Laser Technology Secures RMB 236 Million in Series B Financing for Dental 3D Printing
Nanjing Chamlion Laser Technology Co., Ltd, a leading provider of dental metal 3D printing solutions...
HutchMed’s Elunate Receives NMPA Review for Second-Line Gastric Cancer Treatment
China-based HutchMed (HKG: 0013, NASDAQ: HCM) has announced that the National Medical Products Administration (NMPA)...
HuidaGene Receives CDE IND Approval for Ophthalmology Gene Therapy HG004
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced receiving Investigational New Drug (IND) approval from...
CBMG’s C-CAR031 Shows Promising Results in Phase I Study for Hepatocellular Carcinoma
China-based cell therapy specialist Cellular Biomedicine Group Inc. (CBMG) has published the results of the...
CanSino Biologics Reports 2022 Revenue Drop and Increased Losses Amid COVID-19 Vaccine Market Shifts
China-based vaccines specialist CanSino Biologics Inc., (HKG: 6185) has released its 2022 financial report, recording...
PackGene Secures Series C Financing to Boost AAV Innovation and Global Expansion
China-based PackGene Biotech has announced the successful completion of a Series C financing round, securing...